University of California San Francisco

Kirkpatrick Fergus, MD, MAS

Kirkpatrick Fergus
Kirkpatrick
Fergus
MD, MAS

Chief Resident (PGY-5)
General Surgery

[email protected]

Education

Institution Degree Dept or School End Date
University of California, San Francisco MD 05/2020
University of California, San Francisco MAS Biostatistics & Epidemiology 03/2020
Harvard University AB Social Studies 05/2012

Awards & Honors

Award Conferred By Date
Medical Student Teaching Award UCSF School of Medicine 2026
Clinical Science Scholar San Antonio Breast Cancer Symposium 2025
Naffziger Research Award University of California, San Francisco 2025
ASCO Merit Award American Society of Clinical Oncology 2024
Research Excellence Semifinalist American Society of Human Genetics 2024
Young Investigator Award American Society of Clinical Oncology 2023
Medical Student Travel Award Association for Academic Surgery 2020
Alpha Omega Alpha University of California, San Francisco 2020
MD with Distinction University of California, San Francisco 2020
Excellence in Teaching Award University of California, San Francisco 2019
Cum Laude Harvard University 2012
High Departmental Honors Harvard University 2012
John Marquand Award Harvard University 2012

Grants and Funding

  • NIH Ruth L. Kirschstein Institutional NRSA | 2023-07-01 -
  • American Society of Clinical Oncology | 2023-07-01 -
  • National Institute of Advancing Translational Science | 2018-07-01 - 2019-06-30

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 10
  1. Impact of Population-Based Pathogenic Variant Testing on Risk-Based Breast Screening Recommendations: A Secondary Analysis of the WISDOM Study.
    Shieh Y, Heise RS, Madlensky L, Sabacan LP, Soto IA, Fiscalini AS, Ross K, Goodman D, Blanco A, Brain S, Heditsian DM, Moya J, Fergus KB, Olopade OI, Scheuner MT, Eklund M, Ziv E, Tice JA, van 't Veer L, Esserman LJ, Athena Breast Health Network and WISDOM Study Investigators and Advocate Partners| | PubMed
  2. WISDOM randomized trial comparing risk-based versus annual breast cancer screening: study cohort characteristics and design.
    Fiscalini A, Blum K, Fergus K, Hiatt RA, Naeim A, Kaster A, Scheuner MT, van 't Veer LJ, LaCroix AZ, Borowsky AD, Olopade OI, Park HL, Esserman J, Lancaster R, Heditsian D, Brain S, Lee V, Goodman DL, Ross KS, Wenger N, Parker BA, Madlensky L, Tice JA, Shieh Y, Ziv E, Arasu VA, Anton-Culver H, Kaplan CP, Rhoads KF, Badal K, Hogarth M, Petruse A, Soto IA, Leggat-Barr K, Goodman S, Atamer J, Ryu R, Adduci K, Matthews JB, Eklund M, Athena/WISDOM Network Collaborators and Advocate Partners, Sabacan LP, Esserman L| | PubMed
  3. Risk-Based vs Annual Breast Cancer Screening: The WISDOM Randomized Clinical Trial.
    Esserman LJ, Fiscalini AS, Naeim A, Van't Veer LJ, Kaster A, Scheuner MT, LaCroix AZ, Borowsky AD, Anton-Culver H, Olopade OI, Esserman J, Lancaster R, Madlensky L, Blanco AM, Ross KS, Goodman DL, Tong BS, Hogarth M, Heditsian D, Brain S, Lee V, Blum K, Kim MO, Sabacan LP, Fergus KB, Yau C, Park HL, Parker BA, Kaplan C, Rhoads KF, Eder S, Adduci K, Matthews JB, Wenger NS, Shieh Y, Hiatt RA, Ziv E, Tice JA, Eklund M| | PubMed
  4. Germline Pathogenic Variants Among Women Without a History of Breast Cancer: A Secondary Analysis of the WISDOM Randomized Clinical Trial.
    Fergus KB, Ross KS, Scheuner MT, Blanco AM, Tice JA, Ziv E, Shieh Y, van 't Veer L, Olopade OI, Goodman DL, Tong BS, Harvey H, DeRosa D, Risty L, Silver E, Kaster A, Fiscalini AS, Blum K, Heise R, Sabacan L, Heditsian D, Brain S, Petruse A, Eklund M, Hiatt RA, Borowsky AD, Naeim A, Park HL, LaCroix AZ, Parker BA, Lancaster R, Esserman J, Wenger N, Arasu V, Anton-Culver H, Esserman LJ, Madlensky L| | PubMed
  5. WISDOM Randomized Trial Comparing Risk-Based Versus Annual Breast Cancer Screening: Study Cohort Characteristics and Design.
    Fiscalini A, Blum K, Fergus K, Hiatt RA, Naeim A, Kaster A, Scheuner MT, van 't Veer LJ, LaCroix AZ, Borowsky AD, Olopade OI, Park HL, Esserman J, Lancaster R, Heditsian D, Brain S, Lee V, Goodman DL, Ross KS, Wenger N, Parker BA, Madlensky L, Tice JA, Shieh Y, Ziv E, Arasu VA, Anton-Culver H, Kaplan CP, Rhoads KF, Badal K, Hogarth M, Petruse A, Soto IA, Leggat-Barr K, Goodman S, Atamer J, Ryu R, Adduci K, Matthews JB, Eklund M, Athena/WISDOM Network Collaborators and Advocate Partners, Sabacan LP, Esserman L| | PubMed
  6. The shifting landscape of germline RET pathogenic variants with the introduction of panel testing.
    Onuma AE, Skefos CM, Richardson ME, Pasyar S, Fergus KB, Bassett RL, Hu MI, Perrier ND, Maniakas A, Zafereo M, Waguespack SG, Sosa JA, Grubbs EG| | PubMed
  7. Parathyroid autofluorescence: A conditionally cost-effective tool to reduce postoperative hypocalcemia after total thyroidectomy.
    Fergus KB, Conroy PC, Thiesmeyer J, Kannan A, Gosnell J, Duh QY| | PubMed
  8. Association between ancestry and tumor somatic mutations in a large national cohort of women with breast cancer.
    Fergus KB, Newberg J, Greenstein R, Fejerman L, Carvajal-Carmona L, Collisson E, Dixit N, Frampton G, Huang FW, Neuhausen SL, Ziv E| | PubMed
  9. Integrating breast cancer polygenic risk scores at scale in the WISDOM Study: a national randomized personalized screening trial.
    Fergus KB, Heise RS, Madlensky L, Fiscalini A, Sabacan L, Theiner S, Kapoor S, Soto IA, Blanco A, Ross K, Goodman-Gruen D, Scheuner M, Hu D, Heditsian D, Brain S, Arasu VA, Kaster A, Chapa L, Olopade OI, Eklund M, Tice JA, Ziv E, van 't Veer L, Esserman LJ, Shieh Y, Athena/WISDOM Network Collaborators and Advocate Partners| | PubMed
  10. Health care utilization in young adults with childhood physical disabilities: a nationally representative prospective cohort study.
    Fergus KB, Zambeli-Ljepovic A, Hampson LA, Copp HL, Nagata JM| | PubMed